Research Analysts’ Updated EPS Estimates for December, 6th (CNAT, DEZ, DUE, KGX, OSR, TGB, TGNA, TI, TKC, TKOMY)
Conatus Pharmaceuticals (NASDAQ:CNAT) had its target price reduced by SunTrust Banks, Inc. to $12.00. SunTrust Banks, Inc. currently has a buy rating on the stock.
Deutz (ETR:DEZ) was given a €9.40 ($10.93) price target by analysts at Berenberg Bank. The firm currently has a buy rating on the stock.
Kion Group (FRA:KGX) was given a €64.00 ($74.42) price target by analysts at Berenberg Bank. The firm currently has a buy rating on the stock.
Osram Licht (FRA:OSR) was given a €38.00 ($44.19) target price by analysts at Berenberg Bank. The firm currently has a neutral rating on the stock.
Taseko Mines (NYSEAMERICAN:TGB) (TSE:TKO) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Taseko Mines is focused on acquiring ownership of and advancing exploration and related activities on known mineral deposits that have as their basic characteristic, large tonnage (based on extensive drill testing for continuity) mineralization which, under metals price assumptions that fall within historical averages, are potentially capable of supporting a mine for 10 years and longer. “
TEGNA (NYSE:TGNA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. The firm currently has $15.00 target price on the stock. According to Zacks, “TEGNA benefits from higher paid-up subscribers, both MVPD and OTT subscribers, and increased revenues from political advertisements. Political revenues recorded an all-time high, including presidential election years and came well above the previous mid-term election in 2014. Additionally, TEGNA’s agreement to acquire two leading stations, WTOL and KWES, in Ohio and Texas is expected to boost its market share post acquisition, which is a positive. Moreover, Premion, which is helping the company reach customers beyond its traditional business, has expanded its reach to 200 markets from the earlier 39 markets. However, the company operates in a competitive broadcast TV industry, which has long been grappling with declining advertising revenues. Moreover, shares have also underperformed the industry on a year-to-date basis.”
Telecom Italia (NYSE:TI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “The Telecom Italia Group is engaged principally in the communication sector that operates mainly in Europe, the Mediterranean Basin and South America. This includes telephone and data services on fixed lines (for final retail customers and wholesale providers), the development of fiber optic networks for wholesale customers, BroadBand services, Internet services, domestic and international mobile telecommunications (especially in Brazil), and the television sector using both analog and digital terrestrial technology. The Group also operates businesses in the office products sector. “
Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $6.75 price target on the stock. According to Zacks, “Turkcell is the leading provider of mobile communications services in Turkey. “
Tokio Marine (OTCMKTS:TKOMY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “TOKIO MARINE HOLDINGS INC., formerly known as Millea Holdings, Inc., headquartered in Tokyo, is a Japan-based holding company. Through its subsidiaries and associated companies, the Company is engaged in the non-life insurance, life insurance and asset management businesses. The Company is also engaged in the security investment consultation, investment trust management, derivative, temporary staffing and real estate management businesses. This company became Japan’s first publicly owned holding company that completely integrated life and non-life insurance operations. Their objective is to become one of the world’s preeminent insurance groups within the next 10 years. “
Thermo Fisher Scientific (NYSE:TMO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Over the past three months, Thermo Fisher has successfully outperformed its industry. The company saw strength in all end markets categorized by customer type or geography in the last reported quarter. It particularly registered solid international performance with strong growth in Asia-Pacific including China. Also, a series of product launches with progress in precision medicine initiatives aided its performance. The company’s recently-closed acquisition of Advanced Bioprocessing business from BD should add complementary cell culture products to Thermo Fisher’s bioproduction offerings. Also, the company’s initiative to buy Gatan to boost electron microscopy suite buoys optimism. On the flip side, Thermo Fisher’s business segments are getting impacted by unfavorable business mix. Also, competitive headwinds and escalating costs pose a threat.”
TOKYO ELECTRON/ADR (OTCMKTS:TOELY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Tokyo Electron Limited (TEL) is a company mainly engaged in the manufacture and sale of electronic products for industrial uses. TEL is the largest manufacturer of IC and FPD production equipment in Japan and the third largest in the world. The Semiconductor Manufacturing Equipment segment is engaged in the provision of coaters and developers for wafer processing, plasma etching equipment, thermal processing systems and others. The Flat-panel Display (FPD) Manufacturing Equipment segment is engaged in the provision of coaters and developers for FPD manufacturing, plasma etching/ashing apparatus and others. The Electronic Component and Information Communication Equipment segment provides semiconductor products such as integrated circuits (ICs), computer and network equipment and software. In addition, the Company is also involved in logistics, facility management and insurance businesses. “
Topcon (OTCMKTS:TOPCF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Topcon Corporation develops and sells positioning, eye care and smart infrastructure products. Positioning products include GNSS receivers, machine control systems, precision agriculture systems, and IT site management solutions; Eye care products comprise 3D optical coherence tomography systems, retinal cameras, ophthalmic digital image filing systems, auto refractometers/auto kerato-refractometers, slit lamps, computerized tonometers, lens edgers and meters and ophthalmic laser photocoagulators.; infrastructure products consists motorized robotic total stations, imaging stations, mobile mapping systems, 3D laser scanners, data collectors, theodolites, levels/digital levels, self-leveling construction lasers, pipe lasers and asset management systems. Topcon Corporation is headquartered in Tokyo, Japan. “
Tesla (NASDAQ:TSLA) had its price target boosted by Wolfe Research from $410.00 to $430.00. The firm currently has an outperform rating on the stock.
Volkswagen (ETR:VOW3) was given a €203.00 ($236.05) target price by analysts at Credit Suisse Group AG. The firm currently has a buy rating on the stock.
Receive News & Ratings for Conatus Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conatus Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.